Evofem Biosciences Inc EVFM Stock Quotes and Insider News

Insider Chart Past 6 Months

Technical Chart

Filings by transaction date

Jun 07, 2022 (filed on Jun 07, 2022)

Insider Name:

Atkinson Katherine Cocca

Ownership Type:

Direct Ownership

Securities:

Stock option (right to buy)

Nature of Transaction:

Form 3 : Initial Statement of Beneficial Ownership of Securities

# or value acquired/disposed of:

--

Price:

--
Jun 07, 2022 (filed on Jun 07, 2022)

Insider Name:

Atkinson Katherine Cocca

Ownership Type:

Direct Ownership

Securities:

Stock option (right to buy)

Nature of Transaction:

Form 3 : Initial Statement of Beneficial Ownership of Securities

# or value acquired/disposed of:

--

Price:

--
Jun 07, 2022 (filed on Jun 07, 2022)

Insider Name:

Atkinson Katherine Cocca

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

Form 3 : Initial Statement of Beneficial Ownership of Securities

# or value acquired/disposed of:

--

Price:

--
May 27, 2022 (filed on May 31, 2022)

Insider Name:

Pelletier Saundra L

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

141,000

Price:

$0.35
May 04, 2022 (filed on May 06, 2022)

Insider Name:

O'Brien Anthony Stephen

Ownership Type:

Direct Ownership

Securities:

Stock option (right to buy)

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

6,000

Price:

--
May 04, 2022 (filed on May 06, 2022)

Insider Name:

Kamdar Kim P.

Ownership Type:

Direct Ownership

Securities:

Stock option (right to buy)

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

6,000

Price:

--
May 04, 2022 (filed on May 06, 2022)

Insider Name:

Rutherford Colin

Ownership Type:

Direct Ownership

Securities:

Stock option (right to buy)

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

6,000

Price:

--
May 04, 2022 (filed on May 06, 2022)

Insider Name:

Rarick Lisa Dale

Ownership Type:

Direct Ownership

Securities:

Stock option (right to buy)

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

6,000

Price:

--
May 04, 2022 (filed on May 06, 2022)

Insider Name:

Greer Gillian

Ownership Type:

Direct Ownership

Securities:

Stock option (right to buy)

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

6,000

Price:

--
Feb 18, 2022 (filed on Feb 23, 2022)

Insider Name:

Fitzpatrick Alexander A

Ownership Type:

Direct Ownership

Securities:

Stock option (right to buy)

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

300,000

Price:

--

Filings by filing date

Jun 07, 2022 (filed on Jun 07, 2022)

Insider Name:

Atkinson Katherine Cocca

Ownership Type:

Direct Ownership

Securities:

Stock option (right to buy)

Nature of Transaction:

Form 3 : Initial Statement of Beneficial Ownership of Securities

# or value acquired/disposed of:

--

Price:

--
Jun 07, 2022 (filed on Jun 07, 2022)

Insider Name:

Atkinson Katherine Cocca

Ownership Type:

Direct Ownership

Securities:

Stock option (right to buy)

Nature of Transaction:

Form 3 : Initial Statement of Beneficial Ownership of Securities

# or value acquired/disposed of:

--

Price:

--
Jun 07, 2022 (filed on Jun 07, 2022)

Insider Name:

Atkinson Katherine Cocca

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

Form 3 : Initial Statement of Beneficial Ownership of Securities

# or value acquired/disposed of:

--

Price:

--
May 27, 2022 (filed on May 31, 2022)

Insider Name:

Pelletier Saundra L

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

P - Open market or private purchase

# or value acquired/disposed of:

141,000

Price:

$0.35
May 04, 2022 (filed on May 06, 2022)

Insider Name:

O'Brien Anthony Stephen

Ownership Type:

Direct Ownership

Securities:

Stock option (right to buy)

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

6,000

Price:

--
May 04, 2022 (filed on May 06, 2022)

Insider Name:

Kamdar Kim P.

Ownership Type:

Direct Ownership

Securities:

Stock option (right to buy)

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

6,000

Price:

--
May 04, 2022 (filed on May 06, 2022)

Insider Name:

Rutherford Colin

Ownership Type:

Direct Ownership

Securities:

Stock option (right to buy)

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

6,000

Price:

--
May 04, 2022 (filed on May 06, 2022)

Insider Name:

Rarick Lisa Dale

Ownership Type:

Direct Ownership

Securities:

Stock option (right to buy)

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

6,000

Price:

--
May 04, 2022 (filed on May 06, 2022)

Insider Name:

Greer Gillian

Ownership Type:

Direct Ownership

Securities:

Stock option (right to buy)

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

6,000

Price:

--
Feb 18, 2022 (filed on Feb 23, 2022)

Insider Name:

Fitzpatrick Alexander A

Ownership Type:

Direct Ownership

Securities:

Stock option (right to buy)

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

300,000

Price:

--

News

Biz Brief

Sector: Healthcare	Industry: Pharmaceuticals

See Regulatory Filings on SEC

Company Contact

Address:	12400 High Bluff Dr Ste 600 SAN DIEGO CA 92130-3077
Tel:	1-858-5501900
Website:	https://www.evofem.com
IR:	See website

Key People

Saundra L. Pelletier President, Chief Executive Officer, Director	Justin J. File Chief Financial Officer	Alexander A. Fitzpatrick Executive Vice President, General Counsel, Secretary

Business Overview

Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company. It is engaged in developing and commercializing products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). Its product, Phexxi vaginal gel, is a hormone-free, woman-controlled, on-demand prescription contraceptive gel for women. Its lead clinical program is evaluating Phexxi (using the investigational name EVO100) for the prevention of chlamydia and gonorrhea in women. EVO200 vaginal gel (EVO200), its investigational candidate for the reduction of recurrent bacterial vaginosis (BV), uses the same vaginal potential of hydrogen (pH) modulator platform as Phexxi. It also focuses on developing Multipurpose Prevention Technology (MPT) vaginal gel for indications, including the prevention of human immunodeficiency virus (HIV) in women through Orion Biotechnology Canada Ltd.

Financial Overview

For the three months ended 31 March 2022, Evofem Biosciences Inc revenues increased from $1.1M to $4.3M. Net loss applicable to common stockholders decreased 31% to $32M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Selling & Marketing - Balancing value decrease of 58% to $12.3M (expense).

Employees:	119 as of Feb 28, 2022

Reporting Currency:	U.S. Dollars
Enterprise value:	$137.78M as of Jun 30, 2022
Annual revenue (TTM):	$15.57M as of Jun 30, 2022
EBITDA (TTM):	-$133.05M as of Jun 30, 2022
Net annual income (TTM):	-$282.70M as of Jun 30, 2022
Free cash flow (TTM):	-$107.10M as of Jun 30, 2022
Net Debt Last Fiscal Year:	$99.62M as of Jun 30, 2022
Shares outstanding:	85,459,214 as of Aug 9, 2022
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

INK Ultra Money Free

INK Ultra Money Videos

Evofem Biosciences Inc (PK:EVFM)